We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Corvus Pharmaceuticals
CRVS
$1.1B
| $272K | ﹤0.01% |
+68,064
| New | +$248K |
|
3052
Global Water Resources
GWRS
$212M
| $271K | ﹤0.01% |
26,628
-6,410
| -19% | -$65.9K |
|
3053
Puma Biotechnology
PBYI
$406M
| $271K | ﹤0.01% |
79,101
| – | – |
|
|
CRGX
3054
DELISTED
CARGO Therapeutics
CRGX
| $271K | ﹤0.01% |
65,680
-10,249
| -13% | -$43.9K |
|
3055
Sky Harbour Group
SKYH
$351M
| $270K | ﹤0.01% |
27,644
+12,422
| +82% | +$134K |
|
3056
Motorcar Parts of America
MPAA
$261M
| $265K | ﹤0.01% |
+23,681
| New | +$238K |
|
3057
Contango Silver & Gold Inc
CTGO
$529M
| $265K | ﹤0.01% |
13,611
| – | – |
|
3058
Definitive Healthcare
DH
$72.1M
| $264K | ﹤0.01% |
67,607
-36,071
| -35% | -$114K |
|
3059
Omeros
OMER
$709M
| $263K | ﹤0.01% |
87,618
-26,439
| -23% | -$132K |
|
3060
AMES National
ATLO
$266M
| $263K | ﹤0.01% |
14,751
+163
| +1% | +$2.83K |
|
3061
OP Bancorp
OPBK
$233M
| $262K | ﹤0.01% |
+20,151
| New | +$246K |
|
|
VNET
3062
VNET Group
VNET
$2.05B
| $262K | ﹤0.01% |
37,900
-1,100
| -3% | -$6.59K |
|
3063
Bank7 Corp
BSVN
$471M
| $259K | ﹤0.01% |
+6,194
| New | +$235K |
|
3064
Myomo
MYO
$37.5M
| $259K | ﹤0.01% |
+119,681
| New | +$434K |
|
3065
Clarus
CLAR
$125M
| $258K | ﹤0.01% |
74,360
-14,289
| -16% | -$48.4K |
|
3066
HighPeak Energy
HPK
$967M
| $257K | ﹤0.01% |
26,220
-3,926
| -13% | -$38.7K |
|
|
SEG
3067
Seaport Entertainment Group
SEG
$333M
| $256K | ﹤0.01% |
13,753
+2,875
| +26% | +$55.2K |
|
3068
Cartesian Therapeutics
RNAC
$232M
| $255K | ﹤0.01% |
24,497
-3,372
| -12% | -$35.9K |
|
|
MBX
3069
MBX Biosciences
MBX
$2.95B
| $253K | ﹤0.01% |
22,143
+7,672
| +53% | +$78.2K |
|
3070
Polestar Automotive Holding UK
PSNY
$1.98B
| $253K | ﹤0.01% |
7,870
+5,640
| +253% | +$179K |
|
3071
Priority Technology Holdings
PRTH
$518M
| $252K | ﹤0.01% |
32,441
+7,285
| +29% | +$54.7K |
|
3072
Silvercrest Asset Management
SAMG
$76.4M
| $249K | ﹤0.01% |
15,690
-4,542
| -22% | -$68.6K |
|
|
RAPP
3073
Rapport Therapeutics
RAPP
$1.95B
| $249K | ﹤0.01% |
21,873
| – | – |
|
3074
CVRx
CVRX
$126M
| $249K | ﹤0.01% |
42,289
| – | – |
|
|
BBNX
3075
Beta Bionics
BBNX
$706M
| $248K | ﹤0.01% |
17,044
| – | – |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.